Literature DB >> 16425236

Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment.

Jennifer L Warner-Schmidt1, Ronald S Duman.   

Abstract

The hippocampus is one of several limbic brain structures implicated in the pathophysiology and treatment of mood disorders. Preclinical and clinical studies demonstrate that stress and depression lead to reductions of the total volume of this structure and atrophy and loss of neurons in the adult hippocampus. One of the cellular mechanisms that could account for alterations of hippocampal structure as well as function is the regulation of adult neurogenesis. Stress exerts a profound effect on neurogenesis, leading to a rapid and prolonged decrease in the rate of cell proliferation in the adult hippocampus. In contrast, chronic antidepressant treatment up-regulates hippocampal neurogenesis, and could thereby block or reverse the atrophy and damage caused by stress. Recent studies also demonstrate that neurogenesis is required for the actions of antidepressants in behavioral models of depression. This review discusses the literature that has lead to a neurogenic hypothesis of depression and antidepressant action, as well as the molecular and cellular mechanisms that underlie the regulation of adult neurogenesis by stress and antidepressant treatment. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425236     DOI: 10.1002/hipo.20156

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  249 in total

1.  The role of brain-derived neurotrophic factor genotype, parental depression, and relationship discord in predicting early-emerging negative emotionality.

Authors:  Elizabeth P Hayden; Daniel N Klein; Lea R Dougherty; Thomas M Olino; Margaret W Dyson; C Emily Durbin; Haroon I Sheikh; Shiva M Singh
Journal:  Psychol Sci       Date:  2010-10-04

2.  Hippocampal volume differences in Gulf War veterans with current versus lifetime posttraumatic stress disorder symptoms.

Authors:  Brigitte A Apfel; Jessica Ross; Jennifer Hlavin; Dieter J Meyerhoff; Thomas J Metzler; Charles R Marmar; Michael W Weiner; Norbert Schuff; Thomas C Neylan
Journal:  Biol Psychiatry       Date:  2010-11-20       Impact factor: 13.382

3.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.

Authors:  Jennifer L Warner-Schmidt; Kimberly E Vanover; Emily Y Chen; John J Marshall; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

4.  Extracellular signal-regulated kinase 2 signaling in the hippocampal dentate gyrus mediates the antidepressant effects of testosterone.

Authors:  Nicole Carrier; Mohamed Kabbaj
Journal:  Biol Psychiatry       Date:  2012-01-20       Impact factor: 13.382

Review 5.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

Review 6.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

7.  Neuronal plasticity and antidepressant actions.

Authors:  Eero Castrén; René Hen
Journal:  Trends Neurosci       Date:  2013-02-01       Impact factor: 13.837

Review 8.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain.

Authors:  Louis N Manganas; Xueying Zhang; Yao Li; Raphael D Hazel; S David Smith; Mark E Wagshul; Fritz Henn; Helene Benveniste; Petar M Djuric; Grigori Enikolopov; Mirjana Maletic-Savatic
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

Review 10.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.